TD Securities Maintains Hold on Extendicare, Raises Price Target to $7.5
Portfolio Pulse from Benzinga Newsdesk
TD Securities analyst Jonathan Kelcher has maintained a Hold rating on Extendicare (EXETF) and increased the price target from $7 to $7.5.

March 11, 2024 | 5:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Securities has maintained a Hold rating on Extendicare and raised the price target from $7 to $7.5.
The increase in price target by TD Securities suggests a positive outlook on Extendicare's stock, potentially leading to increased investor interest and a short-term positive impact on the stock price. The Hold rating indicates a cautious optimism, suggesting that while there may be potential for growth, investors should not expect significant short-term gains.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100